Russell Investments Group Ltd. reduced its holdings in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) by 52.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 102,551 shares of the company’s stock after selling 114,231 shares during the period. Russell Investments Group Ltd.’s holdings in Oscar Health were worth $1,344,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Southeastern Asset Management Inc. TN boosted its position in shares of Oscar Health by 52.2% during the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company’s stock valued at $42,082,000 after acquiring an additional 1,073,359 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in Oscar Health by 37.8% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company’s stock valued at $23,403,000 after purchasing an additional 477,634 shares during the last quarter. Man Group plc lifted its holdings in Oscar Health by 344.8% during the 4th quarter. Man Group plc now owns 1,813,216 shares of the company’s stock valued at $24,370,000 after purchasing an additional 1,405,554 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in Oscar Health by 23.8% during the 1st quarter. Victory Capital Management Inc. now owns 285,997 shares of the company’s stock valued at $3,749,000 after purchasing an additional 54,938 shares during the last quarter. Finally, Toronto Dominion Bank bought a new position in Oscar Health during the 4th quarter valued at about $1,008,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
OSCR has been the subject of several analyst reports. Raymond James Financial downgraded shares of Oscar Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 24th. Wells Fargo & Company downgraded shares of Oscar Health from an “equal weight” rating to an “underweight” rating and cut their price target for the company from $16.00 to $10.00 in a report on Friday, July 11th. UBS Group reissued a “sell” rating and set a $11.00 price target (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Piper Sandler cut their price target on shares of Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday, August 14th. Finally, Robert W. Baird reissued a “neutral” rating and set a $14.00 price target (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Four equities research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Strong Sell” and an average target price of $12.07.
Oscar Health Trading Down 0.1%
Shares of NYSE OSCR opened at $17.06 on Thursday. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79. The company has a market cap of $4.41 billion, a PE ratio of -21.06 and a beta of 1.86. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26. The company has a 50-day moving average of $16.14 and a two-hundred day moving average of $14.84.
Oscar Health (NYSE:OSCR – Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The company had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. During the same period in the previous year, the firm posted $0.20 earnings per share. The company’s revenue was up 29.0% on a year-over-year basis. As a group, equities analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
- Five stocks we like better than Oscar Health
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Amazon’s Chart Just Flashed a Pennant Pattern—Here’s What to Do
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Undervalued Stocks Analysts Are Loving Right Now—Should You?
- What is the Euro STOXX 50 Index?
- Williams-Sonoma Q2 Results Prove Its Buy-and-Hold Quality
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.